The 2024 CMSC Annual Meeting Abstract Guide

News
Article

The International Journal of MS Care publishes the abstracts for the CMSC Annual Meeting, which is set to be held May 29-June 1, 2024, in Nashville, Tennessee.

In the coming hours, the International Journal of MS Care, the official journal of the Consortium of Multiple Sclerosis Centers (CMSC), will publish the full text abstracts for the 38th CMSC Annual Meeting, which will take place from May 29 to June 1, 2024, in Nashville, Tennessee. These include all of the key data being presented at the annual meeting.

The abstracts will include platform, poster, and Whitaker Research Track presentations. A limited number of the full text supplements will be printed and available at the CMSC Annual Meeting—but a digital version, including late-breaking abstracts, will be available to all on the IJMSC website at IJMSC.org.

Click here to view the 2024 CMSC abstracts on the IJMSC website.

The abstracts are various topicaly, numbering in the hundreds for this year's meeting. They cover multiple categories from several meeting tracks. Check out the sneak peek below to see some of what you can expect to see in the full-text abstract supplement.

WHITAKER RESEARCH TRACK

  • (WHI01) Cerebrospinal Fluid (CSF) Perturbation of Human Primary Astrocytes to Model the Link Between CSF Pathogenicity and Neurodegeneration in Multiple Sclerosis
  • (WHI02) Identifying Biophysical Markers That Predict Perceived Walking, Balance, and Physical Quality of Life in People With Multiple Sclerosis
  • (WHI03) Preclinical Testing of Novel Small Molecules Inhibits Neurodegeneration: Implications for the Pathogenesis and Treatment of Multiple Sclerosis
  • (WHI04) Health Care–Related Social Determinants of Health Are Associated With Regional Cortical Thickness and Accelerated Brain Aging in People With Multiple Sclerosis
  • (WHI05) Relationship Between Immune Cell Bioenergetics and Disease Status in People With Multiple Sclerosis: A Pilot Study
  • (WHI06) Metabolic Alterations in Multiple Sclerosis and Correlation With Disease Severity

PLATFORMS

  • DISEASE-MODIFYING THERAPIES – 6 total abstracts
  • DISEASE MANAGEMENT – 6 total abstracts
  • NEUROIMAGING – 6 total abstracts
  • NEUROPSYCHOLOGY – 6 total abstracts
  • REHABILITATION – 5 total abstracts

POSTERS

  • COMPLEMENTARY AND ALTERNATIVE THERAPIES – 6 total abstracts
  • CASE REPORTS/CASE SERIES – 22 total abstracts
  • DISEASE-MODIFYING THERAPY – 48 total abstracts
  • EPIDEMIOLOGY AND GENETICS – 12 total abstracts
  • FAMILY AND CAREGIVERS – 3 total abstracts
  • INTERNET AND INFORMATION SERVICES – 4 total abstracts
  • IMAGING – 3 total abstracts
  • MULTIDISCIPLINARY CARE – 9 total abstracts
  • METHODS OF CARE – 9 total abstracts
  • NEUROIMMUNOLOGY AND DISEASE MODELS – 9 total abstracts
  • NONIMAGING BIOMARKERS – 11 total abstracts
  • NEUROPHYSIOLOGY, NEUROPSYCHOLOGY, AND NEUROPSYCHIATRY – 6 total abstracts
  • NEUROPATHOLOGY AND PATHOGENESIS – 2 total abstracts
  • PROGRAMS – 5 total abstracts
  • PSYCHOSOCIAL FACTORS – 6 total abstracts
  • QUALITY OF LIFE AND OUTCOMES – 20 total abstracts
  • REHABILITATION – 17 total abstracts
  • RELAPSE THERAPY – 1 total abstract
  • SELF-CARE – 2 total abstracts
  • SYMPTOM MANAGEMENT – 5 total abstracts
Related Videos
Video 3 - 5 KOLs are featured in "Transitions of Care: Moving Spinal Muscular Atrophy Patients from Pediatric/Adolescent Care to Adult Clinics"
Video 3 - 5 KOLs are featured in "Presentation of Adult Spinal Muscular Atrophy in Clinics"
Fawad Khan, MD, FACNS
Valerie J. Block, PT, DPTSc
Sanjay R. Patel, MD, MS
© 2024 MJH Life Sciences

All rights reserved.